Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Confirmation of a BRAF mutation-associated gene expression signature in melanoma.

Pigment cell research - 1 Jun 2007

Johansson Peter, Pavey Sandra, Hayward Nicholas

Abstract excerpt

Mutations in the BRAF oncogene occur in the majority of melanomas, leading to the activation of the mitogen-activated protein kinase pathway and the transcription of downstream effectors. As BRAF and its effectors could be good melanoma therapy targets, defining the repertoire of genes that are d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Conserved Sequence
Share to Data Interpretation, Statistical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Vectors

Share to Melanoma

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Share to Software

Source

Identifiers

PMID: 17516929
DOI: 10.1111/j.1600-0749.2007.00375.x

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17516929-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Confirmation of a BRAF mutation-associated gene expression signature in melanoma.PMID 17516929Read ↗

Microarray expression profiling in melanoma reveals a BRAF mutation signature.Semantic proximity Read ↗

Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells.Semantic proximity Read ↗

A B-Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted therapies.Semantic proximity Read ↗

Gene expression signature associated with BRAF mutations in human primary cutaneous melanomasSemantic proximity Read ↗

Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma.Semantic proximity Read ↗

Imaging Mass Spectrometry for the Classification of Melanoma Based on BRAF/NRAS Mutational Status.Semantic proximity Read ↗

The immune-related role of BRAF in melanoma.Semantic proximity Read ↗

BRAFV600E Expression Is Homogenous and Associated with Nonrecurrent Disease and Better Survival in Primary Melanoma.Semantic proximity Read ↗

Characterization of the BRAF interactome identifies BRAF <sup>V600E</sup> <=>TP53 interaction in melanomaSemantic proximity Read ↗

Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K- ras mutationsSemantic proximity Read ↗

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic neviSemantic proximity Read ↗

The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.